AdML-TYML

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAdML-TYML
Drug Alias Nameoncolytic adenovirus therapy targeting CD133 (University of Minnesota)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCD133 modulators
TargetsCD133
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A